|
Market Closed -
Nasdaq
00:00:00 13/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.360 USD | -2.22% |
|
+3.21% | +7.18% |
| 10-05 | Biocryst Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board | CI |
| 10-05 | BioCryst Pharmaceuticals Forms Scientific Advisory Board as R&D Model Evolves | MT |
Stock exchange
Nasdaq
BCRX 8.360 $
-2.22%
28.92M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BCRX | 8.360USD | -2.22% | 28.92M $ | ||
CBOE
| BCRX | 8.350USD | -2.45% | 1.36M $ | |
|
Tradegate
| BO1 | 7.492EUR | -1.94% | 1.09K € | |
|
Mexican S.E.
| BCRX * | 152.00MXN | +1.33% | 7.45K $ | |
|
Boerse Muenchen
| BO1 | 7.496EUR | -1.94% | 7.5 € | |
|
Deutsche Boerse AG
| BO1 | 7.550EUR | +3.54% | 0 € | |
|
Börse Stuttgart
| BO1 | 7.500EUR | -1.24% | 0 € | |
|
Berne S.E.
| BO1 | 6.954CHF | -0.63% | 0 CHF |
Quotes 5-day view: BioCryst Pharmaceuticals, Inc.
Delayed Quote Nasdaq
| 05/10/2026 | 06/10/2026 | 07/10/2026 | 08/10/2026 | 09/10/2026 | |
|---|---|---|---|---|---|
| Last | $8.100 | $7.950 | $8.400 | $8.290 | $8.550 |
| Volume | 4,712,254 | 3,944,024 | 5,122,732 | 5,121,765 | 2,307,844 |
| Change | -0.86% | -1.85% | +5.66% | -1.31% | +3.14% |
| Opening | $8.170 | $8.150 | $7.910 | $8.360 | $8.270 |
| High | $8.250 | $8.150 | $8.425 | $8.400 | $8.595 |
| Low | $7.915 | $7.870 | $7.860 | $8.130 | $8.270 |
Performance
| 1 day | -2.22% | ||
| 1 week | +3.21% | ||
| Current month | +0.36% | ||
| 1 month | +1.58% | ||
| 3 months | -15.64% | ||
| 6 months | -11.16% | ||
| Current year | +7.18% | ||
| 1 year | +18.75% | ||
| 3 years | +39.80% | ||
| 5 years | -43.17% | ||
| 10 years | +104.40% |
Volumes
marketsDaily volume
3,459,803
Estimated daily volume
3,459,803
Avg. Volume 20 sessions
5,105,293
Daily volume ratio
0.68
Avg. Volume 20 sessions USD
42,680,249.48
Record volume 1
40,095,470
Record volume 2
37,550,050
Record volume 3
37,366,410
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
2,184,825,147
Net sales (USD)
874,837,000
Number of employees
435
Sales / Employee (USD)
2,011,120
Free-Float
94.69%
Free-Float capitalization (USD)
2,068,777,433
Average Daily Capital Traded
1.95%
Indicators
Moving average 5 days
8.258
Moving average 20 days
8.382
Moving average 50 days
9.114
Moving average 100 days
9.18
Price spread / (MMA5)
-1.22%
Price spread / (MMA20)
+0.26%
Price spread / (MMA50)
+9.02%
Price spread / (MMA100)
+9.81%
STIM
RSI 9 days
44.76
RSI 14 days
42.65
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.22% | +3.21% | +18.75% | +39.80% | 2.18B | |
| +0.03% | -5.67% | +50.74% | +79.07% | 70.61B | |
| +0.66% | -10.08% | +6.97% | +54.49% | 51.01B | |
| +0.31% | +1.49% | +8.84% | +32.81% | 48.1B | |
| +0.90% | -1.46% | +28.68% | +32.69% | 42.78B | |
| +2.21% | -6.61% | +297.85% | +701.45% | 40.67B | |
| -1.15% | -3.11% | +7.15% | +98.83% | 40.3B | |
| +0.45% | -1.20% | +9.11% | +46.80% | 30.59B | |
| -2.23% | -3.48% | +39.06% | +12.14% | 28.16B | |
| -1.16% | -1.84% | -6.31% | -11.99% | 24.36B | |
| Average | -0.22% | -1.76% | +46.08% | +108.61% | 37.88B | |
| Weighted average by Cap. | +0.13% | -2.69% | +50.85% | +119.92% |
Historical Quotes: BioCryst Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
e8813f5ae43fca.Lf0XVabbvHgPPvymA2nGKkAGbw_yUB376vuo0uDq5BY.W4dhI8TrxBtOV6bEbQaBeg4zGT3AOWq9i62ZqI3Hjl11lyYZlKn1OUtUiw
| Date | Price | Volume | Total |
|---|---|---|---|
| 00:00:00 | 8.360 | 426,514 | 3,023,743 |
| 23:59:58 | 8.350 | 111 | 2,597,229 |
| 23:59:57 | 8.350 | 200 | 2,597,118 |
| 23:59:57 | 8.350 | 225 | 2,596,918 |
| 23:59:56 | 8.350 | 192 | 2,596,693 |
| 23:59:56 | 8.350 | 284 | 2,596,501 |
| 23:59:56 | 8.350 | 1,300 | 2,596,217 |
| 23:59:56 | 8.350 | 1,000 | 2,594,917 |
| 23:59:56 | 8.350 | 200 | 2,593,917 |
| 23:59:56 | 8.350 | 100 | 2,593,717 |
Price Extremes
| 1 week | 7.86 |  | 8.6 |
| 1 month | 7.86 | | 9.04 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
Monthly variations
Annual variations
| 2026 | +9.62% | ||
| 2025 | +3.72% | ||
| 2024 | +25.54% | ||
| 2023 | -47.82% | ||
| 2022 | -17.11% | ||
| 2021 | +85.91% | ||
| 2020 | +115.94% | ||
| 2019 | -57.25% | ||
| 2018 | +64.36% | ||
| 2017 | -22.43% | ||
| 2016 | -38.66% | ||
| 2015 | -15.13% | ||
| 2014 | +60.00% | ||
| 2013 | +435.21% | ||
| 2012 | -42.51% | ||
| 2011 | -52.22% | ||
| 2010 | -19.97% | ||
| 2009 | +371.53% | ||
| 2008 | -77.83% | ||
| 2007 | -46.54% | ||
| 2006 | -30.99% | ||
| 2005 | +189.79% | ||
| 2004 | -15.62% | ||
| 2003 | +613.54% | ||
| 2002 | -75.76% | ||
| 2001 | -40.23% | ||
| 2000 | -77.54% | ||
| 1999 | +321.43% | ||
| 1998 | 0.00% | ||
| 1997 | -57.25% | ||
| 1996 | +77.03% | ||
| 1995 | +100.00% | ||
| 1994 | -28.85% |
- Stock Market
- Stocks
- BCRX Stock
- Quotes BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
